@article{34b12c548c8a402d94b975803a27fe6a,
title = "Lung Cancer in the Netherlands",
keywords = "RANDOMIZED PHASE-II, OF-LIFE, RETROSPECTIVE SURVEY, PLUS CARBOPLATIN, STAGE-III, CELL, CHEMOTHERAPY, CARE, MULTICENTER, DOCETAXEL",
author = "Hendriks, \{Lizza E. L.\} and Dingemans, \{Anne-Marie C.\} and \{De Ruysscher\}, \{Dirk K. M.\} and Aarts, \{Mieke J.\} and Lidia Barberio and Robin Cornelissen and Hartemink, \{Koen J.\} and \{van den Heuvel\}, Michel and Ed Schuuring and Smit, \{Hans J. M.\} and \{van der Wekken\}, \{Antonie J.\} and Smit, \{Egbert F.\}",
note = "Funding Information: There is an active Dutch lung cancer patient organization: Longkanker Nederland ( www.longkankernederland.nl ). This organization is committed to saving lives and accelerating lung cancer research and policy while empowering people living with, or at risk for, lung cancer. Longkanker Nederland conducts awareness campaigns, attacks the stigma of the disease, and advocates for more urgency and more funds for lung cancer research. It furthermore gives information to and organizes information days for patients and their relatives. It is funded through a national cancer fund, the Ministry of Health, and donors and sponsors. Funding Information: Stefanie Hofstede and Marjolein Moret-Hartman from the Dutch Knowledge Institution (Kennisinstituut) are acknowledged for providing Figure 2A and B. The authors are grateful to the Dutch Institute of Clinical Auditing for providing the data for the surgical part.",
year = "2021",
month = mar,
doi = "10.1016/j.jtho.2020.10.012",
language = "English",
volume = "16",
pages = "355--365",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "Elsevier Inc.",
number = "3",
}